tetanus toxin

Tetanus toxin (830-843) from tetanus toxoid is a universal human tetanus toxin T cell epitope. It induces T-cell activation and is used as a helper peptide in vaccinations.

Tetanus Toxin (830–844), a biologically active peptide and a tetanus toxin-derived peptide TT830–844 CD4+ T-cell epitope, exhibits promiscuity by binding to a wide spectrum of HLA–DRB molecules. Consequently, it is anticipated to elicit CD4+ T-cell responses across a broad segment of the human population.

Tetanus toxin 830-843 acetate (Tetanus toxin 830-843 acetate (119260-99-0 free base)) from tetanus toxoid is a universal human tetanus toxin T cell epitope. It induces T-cell activation and is used as a helper peptide in vaccinations.

Tetanus toxin peptide, a specific peptide segment isolated from the toxin produced by Clostridium tetani, serves as an immunogen in mice to induce diabetes. It is also utilized in the research of Type 1 diabetes.

Tetanus Toxin (830–844) TFA is a bioactive peptide. It acts as a CD4+ T cell epitope derived from tetanus toxin (TT830–844). This hybrid CD4+ T cell epitope binds to various HLA-DRB molecules, potentially activating CD4+ T cell responses in a broad population.

Tetanus toxin (830-843) TFA is a potent neurotoxin that reaches the cytoplasm of inhibitory spinal neurons through retrograde axonal transport and endocytosis, preventing these neurons from releasing neurotransmitters.

Tetanus toxin (1,301-1,315) (C. tetani) refers to a peptide fragment located at the C-terminal of the heavy chain of the tetanus toxin derived from C. tetani.

Ganglioside GT1b bovine trisodium is a trisialoganglioside that binds to botulinum toxin type A (BTxA), BTxA heavy chain, and tetanus toxin with IC50 values of 11, 0.74, and 7.2 μM, respectively. It acts as a TLR2 agonist in spinal cord microglia, leading to microglial activation, increased expression of pro-inflammatory factors, and heightened pain sensitivity. Additionally, Ganglioside GT1b bovine trisodium reduces the production of IL-6, IL-10, IgG, IgM, and IgA in human peripheral blood mononuclear cells (PBMC). In neuronal cell models, it elevates extracellular glutamate levels. Ganglioside GT1b bovine trisodium is used in the research of immune and neurological disorders.

Ganglioside GT1b is a trisialoganglioside that is characterized by having two sialic residues linked to the inner galactose unit. It binds to the neurotoxins botulinum toxin serotype A (BTxA), BTxA heavy chain, and tetanus toxin with IC50 values of 11, 0.74, and 7.2 μM, respectively.[1] Ganglioside GT1b-containing liposomes bind to the major coat protein VP1 from Merkel cell polyomavirus (MCPyV), which has been identified in Merkel cell carcinomas, identifying ganglioside GT1b as a putative MCPyV receptor. [2] Ganglioside GT1b decreases production of IL-6, IL-10, IgG, IgM, and IgA in human peripheral blood mononuclear cells (PBMCs) by 31.4, 30.5, 60, 59.5, and 58%, respectively, when used at a concentration of 10 μM [3] . Ganglioside GT1b mixture contains ganglioside GT1b molecular species with C18:1 and C20:1 sphingoid backbones.

Siltartoxatug is a humanized IgG1κ monoclonal antibody specifically targeting tetanus toxin (tetanus toxin), with Human IgG1 kappa, Isotype Control serving as its corresponding isotype control.

Vecantoxatug is a humanized monoclonal antibody designed to target Clostridium tetani toxin (TeNT, a neurotoxin). It specifically binds to the tetanus toxin, preventing the toxin from interacting with cell receptors and thus exhibits antitoxin activity. Vecantoxatug holds potential for tetanus research.

Influenza A NP (383-391) (HLA-B27) is a peptide sequence derived from tetanus toxin. It serves as an epitope for CD4+ T helper cells, exhibiting broad immunogenic properties that enhance the response of CD8+ cytotoxic T lymphocytes (CTL). Additionally, this compound is utilized in the research of breast cancer.